dc.contributor.author | S Pirouzpanah | |
dc.contributor.author | F-A Taleban | |
dc.contributor.author | P Mehdipour | |
dc.contributor.author | M Atri | |
dc.contributor.author | A Hooshyareh-rad | |
dc.contributor.author | S Sabour | |
dc.date.accessioned | 2017-10-24T10:48:06Z | |
dc.date.available | 2017-10-24T10:48:06Z | |
dc.date.issued | 2014-Mar | |
dc.identifier.citation | rft.volume=68&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.spage=316&rft.issue=3&rft.epage=23&ctx_ver=Z39.88-2004&rft.jtitle=European+journal+of+clinical+nutrition&rft.date=2014 | |
dc.identifier.issn | 1476-5640 | |
dc.identifier.uri | http://dsp.sbmu.ac.ir/xmlui/handle/123456789/73855 | |
dc.description.abstract | Folate, pyridoxine and cobalamin are coenzymatically essential in one-carbon methyl metabolism, and their deficiencies could explain some alterations during breast carcinogenesis. We aimed to evaluate the validity of folate, pyridoxine and cobalamin estimates from a food frequency questionnaire (FFQ) on the basis of their corresponding fasting plasma biomarkers, in breast cancer (BC) patients. | |
dc.source | European journal of clinical nutrition | |
dc.title | The biomarker-based validity of a food frequency questionnaire to assess the intake status of folate, pyridoxine and cobalamin among Iranian primary breast cancer patients. | |
dc.identifier.doi | 10.1038/ejcn.2013.209 | |